Medicinova inc MNOV.US Value Analysis
MNOV Value Score
3
24
15
- AI analysis rates MNOV with the lowest value score of 1.
- It is mainly due to unstable operating cash flow, along with potential value may be lower.
- Over the past 3 months, MNOV has maintained a consecutive value rating of 1.0, slightly lower than the rating of 1.7 over the past 3 years, indicating slight decrease in enterprise value.
- Compared to all stocks in the Health Care sector, MNOV has a lower value rating.
MNOV Value Reference Factors
The Value score is derived from various data and factor information, integrated through AI algorithms. The following factors are part of the evaluation used by AI value scores.
Update to 2025/03/04 (Weekly Update)
MNOV Financial Forecast
Unit : USD
Update to 2025/5/9 (Quarterly Update)
MNOV Earnings Table
Unit : USD
| QTR | Non-GAAP EPS | EPS YoY | EPS Surprise % | Sales | Sales YoY | Sales Surprise % | NPM |
|---|---|---|---|---|---|---|---|
| Current | -0.07 | 50% | -22.2% | 37.5K | -92.4% | -18.2% | 0.2% |
| 2020Q3 | -0 | 98.4% | -95.1% | 4M | 1,992.3% | -43% | 0% |
Update to 2025/5/11 (Quarterly Update)
MNOV Historical Value Score
You can use historical scores of 3 or above to observe potential performance and make investment decisions.
MNOV Value Strategy Backtest
The following backtest is based on specified rules since 2007. Price chart shows buy/sell time, cumulative returns, and backtesting statistics.
The Backtest Result of MNOV from 2011/09 till Now
- 68.08%
- Cumulative Return
- 3.89%
- Annual Return
- 21.83%
- Volatility
- 0.18
- Sharpe Ratio
Statistics data for entering at or above a Value score of 4 and exiting at or below a Value score of 2 from September, 2011 to May, 2025. (Total Trades: 1)
| MNOV | Sector | US Overall Market | |
|---|---|---|---|
| Wining Rate | 100% | 45% | 54% |
| Avg Return | 51.3% | 62.9% | 72.8% |
| Avg Profit | 51.3% | 197.1% | 165.9% |
| Avg Loss | - | -45.1% | -34.6% |
| Avg Risk-Reward Ratio | - | 437% | 479.2% |
Update to 2025/5/10 (Daily Update)